Atrial septal defect closure in children at young age is beneficial for left ventricular function

Pia Sjöberg1,2, Henning Clausen3,4, Håkan Arheden1,2

  • 1Clinical Physiology, Department of Clinical Sciences, Lund, Lund University, Box 188, 221 00 Lund, Sweden.

Insights

Atrial septal defect (ASD) closure in children improves left ventricular (LV) function and hemodynamics. However, LV volumes remain smaller than in controls post-closure, potentially impacting long-term outcomes.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Physiology
  • Medical Imaging

Background:

  • Atrial septal defects (ASDs) cause right ventricular volume overload.
  • ASD closure doesn't always resolve symptoms or improve exercise capacity, suggesting potential left ventricular (LV) hemodynamic impacts.

Purpose of the Study:

  • To evaluate the effect of ASD closure on non-invasive LV pressure-volume (PV) loops in children.
  • To compare LV hemodynamics in children with ASD before and after closure against healthy controls.

Main Methods:

  • Cardiac magnetic resonance (CMR) imaging and brachial blood pressure were used to derive non-invasive LV PV loops.
  • Twenty-three children with ASD underwent CMR, with 17 re-examined post-closure; 12 controls were included.

Main Results:

  • After ASD closure, LV end-diastolic volume increased but remained smaller than in controls.
  • Children with ASD exhibited higher baseline contractility and arterial elastance compared to controls.
  • Post-closure, contractility and arterial elastance decreased, approaching control levels.

Conclusions:

  • The left ventricle (LV) in children with ASD remains hemodynamically efficient despite the shunt.
  • Early ASD closure is beneficial for LV function due to ventricular compliance.
  • Persistent small LV volumes post-closure may influence long-term cardiovascular risk and exercise performance.
Abstract

Related Concept Videos

Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
10.0K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753